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Abstract. Glycosylinositol phospholipid (GPI) mem-
brane anchors are the sole means of membrane attach-
ment of a large number of cell surface proteins, in-
cluding the variant surface glycoproteins (VSGs) of the
parasitic protozoan, Trypanosoma brucei. Biosynthetic
data suggest that GPI-anchored proteins are synthe-
sized with carboxy-terminal extensions that are im-
mediately replaced by GPI, suggesting the existence of
preformed GPI species available for transfer to the na-
YCOSYLINOSITOL phospholipid (GPI)' membrane
anchors attach many proteins of varied function to
13eukaryotic cell membranes, almost always to the cell
surface (for review see Ferguson and Williams, 1988; Low,
1989; Cross, 1990; Thomas et al ., 1990). It appears that GPI
membrane anchors share an evolutionarily conserved linear
core structure, consisting ofethanolamine-P-6 man al-2 man
al-6 man al-4 G1cN al-6 inositol. This linear sequence links
the phospholipidmoiety to the protein via an amide bond be-
tween ethanolamine and the carboxy-terminal amino acid.
Different anchors have both protein and cell-specific side
chain modifications and differ in phospholipid structure.
Side chain modifications include carbohydrate (galactose,
mannose, and GaINAc), extra ethanolamine phosphate, and
an extra fatty acid attached to an inositol hydroxyl. Acyla-
tion of inositol confers resistance to PI-PLC, an enzyme of-
ten used to diagnose GPI anchoring (Roberts et al ., 1988).
The various GPI lipid moieties described include sn-1,2-
dimyristylglycerol (T . brucei VSG; Ferguson et al., 1985),
1-alkyl-2-acyl glycerol (human erythrocyte acetylcholin-
esterase; Roberts et al., 1988 andLeishmania majorpromas-
tigote surface protease; Schneider et al., 1990), monoacyl-
glycerol (T . brucei procyclic acidic repetitive protein; Field
et al., 1991), and ceramide (Dictyostelium discoideum con-
tact site A glycoprotein; Sadeghi et al ., 1988 ; Stadler et al.,
1989) . The functional significance of these structural varia-
tions is unclear.
Mature GPI-anchored proteins lack a carboxy-terminal
peptide that is encoded in the cDNA sequence. Putative
precursor proteins that contain this extension have been ob-
1. Abbreviations used in this paper: GPI, glycosyl-phosphatidyinositol ;
Inos, inositol; pCMPSA, sodium p-chloromercuriphenylsulphonate; PLC,
phospholipase C; VSG, variant surface glycoprotein.
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scent protein in the ER. Candidate precursor
glycolipids having a linear sequence indistinguishable
from the conserved core structure found on all GPI
anchors, have been characterized in T. brucei. In this
paper we describe the transfer of three GPI variants to
endogenous VSG in vitro. GPI addition is not reduced
by inhibitors of protein synthesis and does not require
ATP or GTP, consistent with a transpeptidation mech-
anism.
served for neural cell adhesion molecule, N-CAM 120 (He
et al ., 1987), and alkaline phosphatase (Takami et a] ., 1988).
Biosynthetic studies suggest that the carboxy-terminal se-
quence is replaced within 1-5 min of completion of protein
synthesis (Bangs et al ., 1985; Ferguson et al., 1986 ; Conzel-
mann et al., 1987; He et al., 1987) . The rapidity of this
modification suggested the existence of a preformed precur-
sor glycolipid that could be transferred en bloc to the newly
synthesized protein concomitant with or after cleavage ofthe
carboxy-terminal peptide extension. Recent studies using a
yeast secretory mutant (sec 18) support an endoplasmic re-
ticulum location for the GPI addition reaction (Conzelmann
et al., 1988).
The abundance of VSG in T . brucei makes this protozoan
parasite a good model for the study ofGPI-anchor structure
and biosynthesis. Two glycolipids, P2 and P3 (Menon et al.,
198ßa [presumably identical to lipids A and C; Krakow et
al., 1986]), with characteristics expected of GPI anchor
precursors have been identified in this parasite. P2 is PI-PLC
sensitive and consists of a linear sequence identical to the
conserved core sequence found on all GPI anchors (Menon
et al., 19ß8a; Mayor et al., 1990b). P3 is PI-PLC resistant
due to the acylation of the inositol hydroxyl by a fatty acid
but is otherwise identical to P2 (Krakow et a]., 1989; Mayor
et al ., 1990a).
The biosynthesis of these glycolipids has been studied in
vivo (Schwarz et al ., 1988) and in vitro (Menon et al.,
19ß8b; Masterson et al., 1990; Doering et al., 1989; Mas-
terson et al., 1989; Menon et al., 1990b). The simplest
model (summarized in Fig. 1) suggested by the available data
is that the lipids are assembled by the sequential glycosyla-
tion of PI followed by the addition ofphosphoethanolamine.
A peculiar feature of trypanosome GPI biosynthesis is the
observation of heterogenously acylated forms of P2 and P3,
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Figure 1. Model for GPI synthesis and transfer to protein. Glycosyl-
phosphatidylinositols (see Table I forcomplete structures) that have
propertiescharacteristic ofpreformed precursors ofGPI membrane
anchors are proposed to be synthesized from PI species via appro-
priate, activated donor molecules, UDPGIcNAc, (Doering et al.,
1989), Dol-PMan, (Menon et al., 1990a) and possibly phosphati-
dylethanolamine (?EthNH2 ; Menon, A. K., S. Mayor, and R. T.
Schwarz, manuscript in preparation). The topography of thesebio-
synthetic reactions is not known but completed GPIs are expected
to be located, with the terminal ethanolamine facing the lumen of
the ER (Lumen), available for transfer to newly synthesized protein
acceptors containing the GPI addition signal. After GPI addition
the protein and GPI anchor may be processed in the ER and/ordur-
ing transport along the secretory pathway.
which are then converted to dimyristyl species via a series
of fatty acid remodeling reactions (Masterson et al., 1990).
The origin and function of the extra fatty acid on the inositol
ofP3 and other biosynthetic intermediates is unknown. Data
consistent with the assembly ofthe free GPI species in the lu-
men of the ER have been presented (Menon et al., 1990a).
Besides their remarkable structural similarities with GPI
anchors, there is no direct evidence that these free GPI spe-
cies aretransferred to protein. Pulse-chase experiments have
proved inadequatein establishing their role in GPI anchoring
because these lipids turn over rapidly in the presence or ab-
sence of protein synthesis inhibitors (Menon et al., 1988a;
unpublished observations). Cell free systems to study GPI
additionto in vitrotranslatedpolypeptides containingthe car-
boxy-terminal extension have been described. In one set of
experiments, using CHO cell membranes, placental alkaline
phosphatase and site-directed mutants were selectively pro-
cessed to cleaved forms lacking the carboxy-terminal hydro-
phobic sequence (Bailey et al., 1989 ; Micanovic et al.,
1990). In a separate report, Thy-1 anddecay accelerating fac-
tor were processed to PI-PLC sensitive forms (Fasel et al.,
1989)in the presence of dog pancreas membranes. However,
direct evidence for the transfer of GPI components to protein
was not demonstrated in either of these systems.
In this paper, we report experiments demonstrating the
transfer of radiolabeled GPI precursor molecules to VSG in
a cell free system from T. brucei, providing direct evidence
that the free GPI molecules are bona fide precursors of the
membrane anchors of GPI-linkedproteins. We also describe
some properties of the GPI addition reaction.
Materials and Methods
Materials
Guanosine diphospho-[3,4-3H]mannose (20 Ci/mmol) and uridine diphos-
pho-N-acetyl-D-[6-3H]glucosamine (26.8 Ci/mmol) were purchased from
Du Pont-New England Nuclear (Boston, MA). GDPMan, UDPGIcNAc,
ATP, GTP, 0-y-imidoadenosine-5'-triphosphate, 0-,y-methyleneadenosine-
5'-triphosphtae, 0-y-imidoguanosine-5'-triphosphate and guanosine 5'-O-
(3-thiotriphosphate) were purchased from Sigma Chemical Co. (St. Louis,
MO). Protein synthesis inhibitors (cycloheximide, puromycin, and aniso-
mycin), protease inhibitors (TLCK, PMSF, leupeptin, aprotinin) and Co-
enzyme A were also purchased from Sigma. Endo-ß-N-acetylglucosamini-
dase H, creatine phosphate, rabbit muscle creatine kinase, and proteinase
K were obtained from Boehringer Mannheim Biochernicals (Indianapolis,
IN). Tunicamycin was purchased from Calbiochem-Behring Corp. (La
Jolla, CA). PI-specific phospholipase C from Bacillus thuringiensis was a
gift from Martin Low (Columbia University). Neutral glycan standards de-
rived from glycolipid anchors of VSGs 117 and 118 and glucose oligomer
standards were prepared as described elsewhere (Mayor et al., 1990b). An-
tibodies to VSGs 117 and 118 were raised against purified sVSG as previ-
ously described (Cross, 1979). 118 antiserum was used directly as a source
ofantibodies for 118 VSG and anti-117 antibodies were purified by affinity
chromatography over sVSG 117 coupled to Sepharose as previously de-
scribed (Ferguson et al., 1986). All other chemicals were of reagent grade
or the highest purity obtainable unless otherwise mentioned.
Preparation ofthe Cellfree System
Rats were inoculated with trypanosome variants of the Molteno Institute
Trypanozoon antigenic type 1.4 or 1.5 (clones 117 or 118, respectively) of
T. brucei strain 427. "Buffy-coat" trypanosomes were purified by centrifuga-
tion and used directly, or after passage through a DEAE column as previ-
ously described (Cross, 1975). Trypanosomes were incubated withor with-
out tunicamycin (400 ng/ml) at 1 x 108 cells/ml in RPMI medium for 30-
60 min as previously described (Mayor et al., 1990a). The cells were pel-
leted by centrifugation, lysed, and frozen as described (Masterson et al.,
1989). 1 ml of the frozen lysate (5 x 108 cell equivalents) was thawed at
room temperature, transferred to9 ml ofice-cold buffer 1 (25 mM K-Hepes
pH 7.4, 75 mM KAc, 5 mM MgAc2, 1 mM TLCK, 1 pg/ml leupeptin, 1
or2 mM DTT), andcentrifuged at 10,000g at 4°C. Thepelleted membranes
were washed twice in the same buffer and finally resuspended in ice-cold
buffer 2 (buffer 1 containing 10 mM MnACZ). The membranes were resus-
pended in a Dounce homogenizer equipped with a tight fitting pestle (10
strokes) and kept on ice until required.
Labeling ofGPISpeciesandEndogenousAcceptorsIn
lrtro viaSugar Nucleotides
A standard reaction contained 5 x 10' cell equivalents of dispersed mem-
branes in a total volume of 100 pl of buffer 3 (buffer 2 containing 1 mM
CoA, 200 ng/rnl tunicamycin, 1 mM ATP, 10 mM creatine phosphate,
8 U/ml creatine kinase). Radiolabeled precursors (1-2 PCi of GDP-[3H]Man
or UDP-[3H]G1cNAc) were added to initiate the reaction and samples were
incubated at 37°C in a water bath. In incubations with UDP-[3H]G1cNAc,
1 mM GDP-Man was included inthe reaction, whereas 1 mM UDPGIcNAc
was added to incubations where the radiolabel used was GDP-[3H]Man. In
some GDP-[3H]Man labeling experiments the reaction mixture was prein-
cubated (10-15 min at 37°C) in the absence of the radiolabel but with 0.2
pM GDP-Man. The labeling reaction was initiated by the addition of the
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--0 Modifications on core GPI structure 9 PI species1-2 pCi of GDR['H]Man followed by UDP-GIcNAc (I MM final concen-
tration). After the incubation an aliquot (N50%) of the reaction was trans-
ferred to an equal volume ofsolubilization buffer (0.375 mM Tris-HCI, pH
6.8, 4% SDS) at 100°C and boiled for 5 min before being subjected to SDS-
PAGE and fluorography. The remainderofthereactionmixture was analyzed
for GPI synthesis as described (Masterson et al., 1989) except that TLC
oftheglycolipids wasperformed withKieselgel-60 thin-layer plates (Merck,
Darmstadt, FRG) using a modified solvent system, chloroform/methanol/
water (4:4:1; vol/vol/vol) and the radioactivity in each lane detected as de-
scribed previously (Mayor et al., 1990x).
SDS-PAGE and Quantitation ofRadioactivity
Incorporated into Protein
An aliquot of the solubilized reaction mixture was boiled (3 min, 100°C)
with 0.2 vol ofglycerol/DTT (50% glycerol, 0.5 M DTT, 0.25% bromophe-
nol blue) and loaded on 16-cm 7.5 % SDS polyacrylamide gels (Laemmli,
1970). The stacking gel was 4% acrylamide. The gels were run for 10-
12 h, stained with Coomassie brilliant blue, impregnated with EN3HANCE
(Du Pont-NEN) and exposed to preflashed Kodak XAR-5 film at -70°C.
Molecular weight markers ("pre-stained" markers and SDSVII) were from
Sigma Chemical Co. 1b quantitate the radioactivity transferred to protein,
the labeled bands were located on the gel and excised. The gel slices were
dissolved in 80% Protosol (DuPont-NEN) at room temperature for 14 h,
neutralized with glacial acetic acid, mixed with scintillation fluid, and taken
for liquid scintillation counting (Packard Instrument Co., Downers Grove,
IL).
Purification ofRadiolabeled GPI Moleculesfor Use
as Substratesfor the Transfer Reaction
GPI species were labeled via GDR[3H]Man as described above and puri-
fiedby TLC (Mayor et al., 1990x) or as describedbelow. Thepurified lipids
were rechromatographed and determined to be >90% radiochemicallypure.
(P2 and P3 samples were >99% pure [Mayor et al., 1990a,b], whereas im-
purities in P2'and P2"were mainly P2"and P2, respectively.) For some ex-
periments glycolipids were purified by column chromatography (1.5 x
25 cm; Iatrobeads, Iatron Laboratories, Japan) following the procedure de-
scribed by Masterson et al. (1989) or by phase separation as described be-
low. The radiolabeled glycolipids extracted into the butanol phase from an
in vitro reaction were vacuum-dried in a Speed Vac (Savant Instruments,
Hicksville, NY) and redissolved in 500141 chloroform/methanol (CM; 2:1).
100Fel of4 mM MgC12 solution was added tocreate two phases. The meth-
anol-rich upper phase was separated and washed with an equal volume of
artificial lower phaseand the chloroform-richlower phase was washed with
an equal volume of artificial upper phase. The upper methanol-rich phase
contains P2, P2" and P2' (>95%) while the lower chloroform-rich phase
contains P3 and the less polar GPI species as well as dol-P-man. The upper
methanol-rich phase was occasionally used without further purification as
a substrate for the transfer reaction. P3 was purified (purity >99%) from
the lower phase either by thin layer or column chromatography before use
as a substrate in the transfer reaction.
Transfer ofPurified GPI Species to Endogenous
Acceptors in the Cellfree System
Purified GPI species were dried in vacuo in conical centrifuge tubes. The
lipids were resuspendedin buffer2 containing 10 times the final concentra-
tion (wt/vol) of Triton X-100. This suspension was sonicated for 10 min
(bath sonicator) or gently vortexed to disperse theglycolipid and the mem-
brane preparation (9 vol; 5 x 107 cell equivalents in buffer 3) was added
to this dispersion. The tubes containing the reaction mixture in a final vol-
ume of 50 or 100 pl were transferred to 37'C and the reaction processed
as above exceptthat alargeraliquot(90%) ofthe reaction mixture was taken
for SDS-PAGE analyses. In all instances the intact GPI species that were
recovered at the end ofthe reaction were unchanged as assessed by TLC.
Enzymatic Theatmentsofthe Labeled Pblypeptides
Solubilized reaction mixtures from labeling reactions were pooled. The re-
sulting pooled lysate was divided into two aliquots and precipitated with 10
vol ofice cold acetone at -20°C for 3 h and centrifuged at 4°C at 13,000 g
for 15 min. The protein precipitate was recovered after being washed once
with ice-cold acetone. The precipitates were solubilized in 100 pl PI-PLC
Mayor et al. GPI Transfer to Protein in Vitro
buffer (0.1 M Tris-HCI, pH 7.4, 0.1% sodium deoxycholate) and incubated
at 37°C without or with 1 hg of R thuringiensis PI-PLC for 3 h. Control
incubations were performed with similarly treated [35S]methionine-labeled
mfVSG (Ferguson et al., 1986). At the end of the incubation the reactions
were reprecipitated with acetone and the precipitates were analyzed by
SDS-PAGE and fluorography. Analyses of PI-PLC treated VSG species by
Triton X-114 detergentphaseseparation were carried outas described (Con-
zelmann et al., 1988). Endo H digestions ofpolypeptides labeled via GDR[3H]Man
in vitro were carried out on solubilized reaction mixtures. 10 Al
of0.2 M DTT in 0.1 M Na-POs, pH 5.5 buffer was added to each of two
aliquots of 10 ul of the solubilized mixture and boiled for 3 min. 170 pl
of0.1 M Na-PO4, pH 5.5 containing protease inhibitors (2 leg/ml leupep-
tin, 1 Fag/ml aprotinin, 0.1 M PMSF) and 10 ug ofBSA was added to each
aliquot and incubated with (10 mU) or without enzyme at 37'C for 14-
16 h, precipitated with ice-cold acetone, and analyzed by SDS-PAGE and
fluorography.
Immunoprecipitation ofthe LabeledPolypeptides
Labeledpolypeptideswere directlyimmunoprecipitated fromthesolubilized
labeling reactions. 30-pl aliquots of the solubdized reaction were added to
300 /Al of TEN buffer (150 mM NaCl, 50 mM Tris-HCI, pH 7.5, 5 mM
EDTA, 1% NP-40 [wt/vol]) containing 10 F<l ofthespecificpurified antibody
(1.0 mg/ml) or 20 Al of the relevant antisera and protease inhibitors. This
solution was incubated for 1 h at room temperature, 100 Fel of Protein A
Sepharose CL-4 beads (Pharmacia Fine Chemicals, Piscataway, NJ) was
added to each tube, and the samples were incubated for an additional 12 h
at4°C. The beads were pelleted and washed once with 1 ml of TEN buffer
containing 0.6 M NaCI and 3 mg/ml BSA followed by 1 ml of TEN buffer
containing 0.6 M NaCI and twice with 1 ml ofTEN. The washed pellet was
boiled with solubilization buffer containing 0.2 volglycerol/DTT (50% glyc-
erol, 0.5 M dithiothreitol, 0.25 % bromophenol blue), centrifuged, and the
supernatants were analyzed by SDS-PAGE followed by fluorography.
Characterization ofthe Labeled Moiety Transferred
to Endogenous Acceptor
Thesolubilizedlysates oftwo GDR[3H]Manlabelingreactionswerepooled
and chromatographed on SDS-PAGE. The gels were stained with Coomas-
sie brilliant blue and polypeptides migrating in the 48-58-kD molecular
weightrange wereexcisedfromthegelandelectroelutedasdescribed(Hunka-
pillar et al., 1983). The electroeluted protein was recovered in 300 Fcl of
0.02% SDS in 0.01 M NH4HC03. An aliquot (50 Fvl) was taken for analysis
by SDS-PAGE and fluorography and the remaining was dried in a Speed-
Vac. The dried residue was treated with ice-cold aqueous HF (50%) and
the aqueous soluble radioactivity was deaminated and reduced to obtain a
neutral glycan. The radiolabeled glycanwasmixed with neutral glycan stan-
dards and analyzed by anion exchange HPLC (Mayor et al., 19906).
Protease Protection
1.9 x 108 cell equivalents of the membrane preparation were incubated
with GDR[3H]Man under standard conditions in a final volume of 275 Al
for 90 min and then transferred to an ice-water mixture. CaC12 was added
to a final concentration of 2.5 mM and the mixture divided into 20-Al ali-
quots. Proteinase K (20 U/mg) was added to each aliquot in the absence
or presence of 1% Triton X-100. After incubation (final volume 30 Al) at
0°C for 45 minPMSF was added to a final concentrationof2 mM . An equal
volume ofboiling solubilization buffer was added to each tube and the solu-
bilized mixture analyzed by SDS-PAGE and fluorography.
Protein Synthesis
Membranes (2.5-5 x 101 cell equivalents) were incubated at 37°C for
60 min in buffer 3 containing 0.2-1 mM GTP along with [35S]methionine
(0.5 mCi/ml), a mixture of 19 unlabeled amino acids excluding methionine
(at 30 uM each) and 1 mM GDP-Man. De novo protein synthesis in the in
vitro system was measured by [35S]methionine incorporation into protein
species. Labeled samples were analyzed by SDS-PAGE and fluorography
andquantitated by TCA precipitation and liquidscintillation counting as de-
scribed elsewhere (Ferguson et al ., 1986). The effectofprotein synthesisin-
hibitorson GPI addition in vitro was determined by preincubating the mem-
branes with protein synthesis inhibitors for 10 min at 0°C. In experiments
involving the incorporation of GDP-[3H]Man into GPI species GTP (1 mM
final concentration) was added 15 min after the addition of the radiolabel
as GTP appears to inhibit GDP-[3H]Man incorporation into GPI species.
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Synthesis ofGPIs In Vitroand Tlmnsfer toEndogenous
Protein Acceptors
Severn recent papers have described the cell free synthesis
of GPI species using crude preparations of trypanosome
membranes (Masterson et al ., 1989 ; Menon et al ., 1990b) .
Trypanosome membranes are also capable of synthesizing
dolichol-linked oligosaccharides (Menon et al ., 1990b) and
transferring them to peptide substrates and endogenous pro-
tein acceptors (Ip, H . S., andA . K . Menon, unpublished ob-
servations), similar to the activities present in mammalian
and yeast cell free systems (Paradi et al ., 1972 ; Turco et al .,
1977 ; Hart et al ., 1979) . To investigate specifically GPI bio-
synthesis and transfer and avoid complications in the protein
labeling patterns due to N-glycosylation in vitro,membranes
were prepared from cells treated with tunicamycin, a specific
inhibitor of the first step in the synthesis of dolichol-linked
oligosaccharides (Schwarz and Datema, 1982) . T1lnicamycin
was also included in the in vitro assay to prevent de novo syn-
thesis ofdolichol-linkedoligosaccharides . Whenmembranes
prepared in thisway were incubated with UDR['H]G1cNAc,
no incorporation ofradioactivity into dolichol-linked oligo-
saccharide was observed (data not shown) . However, syn-
thesis of GlcN-PI and its mannosylated derivatives was not
inhibited (data not shown and Doering et al ., 1989) . In all
the experiments described below, unless otherwise men-
tioned, membranes were prepared from tunicamycin-treated
trypanosomes (variant clone 117) and incubated in the pres-
ence of tunicamycin .
When membranes were incubated with GDR[3H]Man in
the absence of added UDP-G1cNAc, only dol-P-[ 3H]Man
(Menon et al ., 1990a,ó) was synthesized in significant
amounts (Fig . 2 A, a) . The insignificant incorporation of ra-
dioactivity intoGPI species and into high-mannose dolichol-
linked oligosaccharides (Man6_ 9G1cNAc2-RP-dol), under
conditions where dol-P-[3H]Man was synthesized in an un-
impaired fashion, indicated that the membranes were effec-
tively depleted of precursors of the N-glycosylation pathway
and of G1cN-PI (in many experiments, to ensure that the cell-
free system was completely depleted of precursors of the
mannose-containing dolichol-linked oligosaccharides that
are synthesized via dol-P-Man [Chapman et al., 1980], the
membranes were preincubated with low concentrations of
GDP-Man [0.2 jiM] for 5 min before labeling with GDR[3H]Man) .
Incubation of membranes in the presence of
UDP-GlcNAc resulted in the synthesis ofa spectrum of GPIs,
including P2, P3 and the fatty acid remodeling intermediates
P2' and P2" (Fig. 2 A, b ; see Table I for structures) .
To detect transfer of in vitro synthesized [3H]Man-labeled
GPIs to endogenous acceptor polypeptides, the cell free sys-
tem was incubated with GDR[3H]Man as described above
and the labeled proteins were analyzed by SDS-PAGE . No
radiolabel was incorporated into any protein species ifUDP-
GlcNAc was omitted from the reaction (Fig . 2 B, lane a) . In
the presence of 1 mM UDRG1cNAc, radioactivity was in-
corporated into protein species migrating in the molecular
weight range (48-58 kD) expected for the differently gly-
cosylated forms ofmembrane-formVSG (mfVSG) (Fig. 2 B,
lane b) .
Fig . 2 C shows the time course of incorporation of [3H]-
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Figure 2. Labeling ofGPI species and endogenous proteins in vitro.
Trypanosome membranes (5 x 107 cell equivalents/reaction) from
variant clone 117 were preincubated at 37°C in buffer 3 (Materials
and Methods) for 5 min in the presence of0.2 I.MGDP-Man . The
labeling reaction was initiated by adding 2 uCi ofGDRPH]Man
(1.4 t&M) and the incubation continued for an additional 15 min .
UDP-GlcNAc (final concentration 1 mM) was then added to some
of the tubes to initiate GPI synthesis and all the tubes were incu-
bated for 90 min and processed as described (Materials and Meth-
ods) . (A) TLC scans of aliquots of the organic extract containing
glycolipids labeled via GDR[3H]Man in the absence (a ; 1.25 x
107 cell equivalents) or presence (b ; 2 .5 x 106 cell equivalents) of
UDP-G1cNAc . P2, PT, P2", and P3 are GPI molecules (see Table
I), Doi-P-Man is dolichol-phosphomannose, the peaks chromato-
graphingbetweenP3 and Dol-P-Manareputativebiosynthetic inter-
mediates in the synthesis of P2 and P3 (Masterson et al ., 1989,
1990 ; Menonet al ., 1990a) . Dol-PP-oligosaccharides (dol-PP-Glc-
NAc2Man69) chromatograph between P3 and the origin. f, front .
(B) SDS-PAGE and fluorographic analyses of 8 x 106 cell equiva-
lents ofSDS solubilized reactions containing membranes prepared
from tunicamycin-treated variant clone 117 and incubated in the
presence or absence of 1 mM UDP-GlcNAc as indicated . (C) Time
course of radioactivity incorporated into protein migrating in the
region of 48-58-kD in SDS-PAGE analyses of analogous in vitro
incubations as described above, except that the membranes were
not preincubated with 0.2 uM GDP-Man prior to the addition of
the radiolabel and UDRG1cNAc . Radioactivity was quantitated as
described in the text .
64Figure 3 Characteristics of the labeled polypeptides . (A) Immuno-
precipitation of 0.8 x 10' cell equivalents of a solubilized in vitro
labeling reaction as described in Fig. 2 B with antibodies to VSG
117 (lane 1) and antiserum to VSG 118 (lane 2) . (B) SDS-PAGE
analyses oflysates from tunicamycin-treated 117 trypanosomes la-
beled with [ 35S]methionine (lanes 1 and 2 ; 2 x 106 cell equivalents ;
as described in Ferguson et al . (1986), and from in vitro reactions
(lane 3 and 4; 2 x 107 cell equivalents) as described in Fig . 2 B,
which were incubated in the presence (lanes 2 and 3) or absence
(lanes 1 and4) ofH thuringiensis, PI-PLC. (C)SDS-PAGEanalyses
of protein species labeled in vitro as described in Fig . 2 B (lanes
1 and 2 ; 8 x 106 cell equivalents) and incubated in the presence
(lane 2) or absence (lane 1) of Endo H .
Man into endogenous protein acceptors . The incorporation
of radiolabel into protein ceased after -60 min while GPI
synthesis continued (data not shown) .
Properties oftheLabeledPblypeptide
The molecular weights of the in vitro labeled polypeptides
suggested that they were glycosylated and unglycosylated
mfVSG (variant 117, Fig . 2 B) . To confirm their identity, it
was shown that both the radiolabeled bands from a trypano-
some 117 membrane incubation could be quantitatively pre-
cipitated with rabbit antiVSG 117 antibodies but not with
antiserum to a different VSG (Fig . 3 A) .
TableL Structures ofEthanolamine-containing GPIs
in T . brucei
GPI species
￿
Structure of GPI'
P2
￿
E-P-Man3GlcNInos-P-1, 2-dimyristylglycerol
P2' E-P-Man3GleNInos-P-1-stearyl-2-acyltglycerol
P2"
￿
E-P-Man3GlcNInos-P-1, 2-diacyltglycerol
P3
￿
E-P-Man3GIcN acyl§Inos-P-1, 2-dimyristylglycerol
PPl
￿
E-P-Man3GIcN acylflnos-P-1-monoacylllglycerol
" The structures of GPIs are taken from the following references : P2 and P3,
Menon et al ., 1988 andMayor et al ., 1990a,b (presumably identical to lipids
Aand C, Krakow et al ., 1986 ; Krakow et al ., 1990) . P2' and P2" (presumably
identical to lipids A" and A', respectively), Masterson et al ., 1990 . PP I, Field
et al ., 1991 .
t Fatty acids other than myristic acid.
4 The inositol residue is esterified with palmitic acid as determined by biosyn-
thetic labeling (Mayor et al ., 1990a ; Field et al ., 1991).
II The glycerol fatty acid is stearic acid as determined by biosynthetic labeling
(Field et al ., 1991) .
E, ethanolamine ; Inos, inositol ; P, phosphate .
Mayor et al . GPI Transfer to Protein In Vitro
When solubilized cell free reactions were incubated with
Bacillus thuringiensis PI-PLC, the in vitro [3H]Man4abeled
VSGs displayed a mobility shift (Fig. 3 B), consistent with
the labeledVSG species having PI-PLC-susceptible GPI an-
chors (Ferguson et al ., 1986) . Both the labeled VSG spe-
cies partitioned into the detergent phase when analyzed by
TX-114 detergent phase separation (Bordier, 1981) . After
PI-PLC treatment, the VSG species were recovered in the
aqueous phase (data not shown) .
Mature mfVSG 117 is completely susceptible to Endo H
digestion resulting in a product that is indistinguishable by
SDS PAGE analyses from non N-glycosylated mfVSG ob-
tained from tunicamycin-treated trypanosomes (data not
shown) . Endo H digestion of the two in vitro labeled VSG
species generated one band corresponding to the faster mi-
grating species that cochromatographed with mfVSG 117
from tunicamycin treated trypanosomes (Fig . 3 C) . These
results confirmthat the slower migrating species corresponds
to fully glycosylatedmfVSG and the faster migrating species
corresponds to unglycosylated mfVSG, suggesting that both
glycosylated and unglycosylated forms of the acceptor VSG
polypeptide are present in this membrane preparation .
To characterize the radiolabeled moiety transferred to
VSG in vitro, [3H]Man-labeled VSG was purified by electro-
elution from SDS gels. Re-analysis of an aliquot of the puri-
fied material showed that all the radiolabel chromatographed
as two bands comigrating with glycosylated and unglyco-
sylated mfVSG (data not shown) . The remainder ofthe puri-
fied VSG was subjected to glycan analysis (Mayor et al .,
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Figure 4 . HPLC analysis of the radiolabeled moiety transferred to
endogenous VSG acceptors. Pblypeptides labeled in vitro from 2.5
x 107 cell equivalents were gel-purified and the recovered radio-
activity (3,000 cpm) was dephosphorylated, deaminated, and re-
duced . The resultant material was deionízed, andchromatographed
on a high pressure anion-exchange HPLC system (Dionex) along
with neutral glycan standards as described previously (Mayor et
al ., 1990b) . The symbols (") at the top ofthe chromatogram indi-
cate the retention time of neutral glycan standards derived from
the membrane anchor of purified VSGs, i.e ., Man3(2,5-anhydro-
mannitol) (Man3AHM) from nongalactosylated 118 VSG and
GalMan3AHM, where n = 2, 3, 4 (indicated as 2, 3, 3, and
4) from heterogeneously galactosylated VSG 117 (Mayor et al .,
19906) . AHM, 2,5-anhydromannitol .Figure S. Protease protection of in vitro labeled VSG. Equal ali-
quots ofGDR[3H]Man-labeled membranes (1.3 x 107 cell equiva-
lents) were incubated (see Materials and Methods) with indicated
concentrations of PMSF, proteinase K, and Triton-X (1% wt/vol
final concentration) in a final volume of 30 Al, at 0°C for 45 min .
ThenPMSF (2 mM, final concentration) was added to each reac-
tion and all the samples were analyzed by SDS-PAGE and fluorog-
raphy as described . The regions ofthe gel corresponding to the mi-
gration position ofmfVSG 117 species (shown above) were excised
and theradioactivity ineach gel slice was quantitated . Radioactivity
in lane 1 is 4,760 cpm and in lane 9 (control ; protease treatment
in the presence ofPMSF) is 3,475 cpm .
19906) .Thesample was treatedwith aqueousHF(aprocedure
expected to release a glycan in phosphodiester linkage) and
the released aqueous-soluble glycan was deaminated and re-
duced . Greater than 95% ofthe radioactivity associated with
the labeled VSG species was recovered from this procedure
as a neutral species . Analysis of this material by anion-
exchangeHPLC (Mayor et al ., 19906) revealed a single peak
with aretention time of 13.3 min (Fig . 4) . This peak co-chro-
matographs with a glycan moiety, Man«1-2Mancd-óManal-
4(2,5-anhydromannitol), that is derived by an identical pro-
cedure from the non-galactosylated GPI anchor of VSG 118
as well as the glycolipids P2 and P3 (Mayor et al., 19906) .
This result confirms that a glycan, corresponding to the core
glycan of a non-galactosylated GPI anchor, is transferred to
endogenous protein acceptors in this in vitro system and pro-
vides further evidence that the ['H]Man-labeling of theVSG
species is confined exclusively to its GPI membrane anchor.
To address the possibility that the GPI addition reaction
observed in vitro could be the result ofan exchange reaction,
a pulse-chase experiment was performed . The inability of
excess unlabeledGDRMan (1 mM) to chase out the radioac-
tivity already incorporated into VSG during a 30-min GDP-
[3H]Man (1 AM) labeling pulse suggests that an exchange
reaction where newly synthesized GPIs are exchanged into
GPI anchorsofpreexisting GPI-anchoredVSG is not involved
in GPI addition toVSG in vitro . In a control experiment, the
membrane preparation was shown to be capable of synthe-
sizing and transferring GPIs to the endogenous VSG accep-
tors during the "chase period" : after a 30-min preincubation
in the absence ofGDRMan, addition of GDP-[3H]Man for
30 min resulted in equally efficient radiolabeling of acceptor
polypeptides .
Protease protection experiments were performed to deter-
mine the location of in vitro-labeledVSG (Fig . 5) . Coomas-
sie staining ofSDS-PAGE gelsofproteasetreated membranes
showed no stained bands in the molecular weight range ex-
pected for VSG, whereas the most prominent stained protein
in the untreated membranes corresponded to VSG (data not
shown) . At 22 .7, 91, and 227 14g/ml protease concentration,
22, 24, and 11% of the labeled polypeptides, respectively,
were protected from proteolytic degradation . A small but
significant portion (3%) of the labeled protein bands was
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resistant to digestion by the protease even at the highest pro-
tease concentration (910 pg/ml) used . In the presence of de-
tergent (1% wt/vol Triton X-100), even at the lowest concen-
tration of protease (22 .7 Pg/ml), there was no detectable
protease protection of the labeled polypeptide species . The
protease could be inactivated by including 1 mM PMSF in
the incubation (Fig . 5, lane 9) . The data indicate that some
of the in vitro labeled (GPI-anchored) VSG molecules reside
in sealed compartments in this cell-free system, and the
amount of protease-protected VSG constitutes a very small
portion of the bulk (Coomassie staining) VSG population .
71ransfer ofPurified P2 to Endogenous VSG Acceptors
To detect transfer of exogenously added GPI species to en-
dogenous VSG acceptors, P2 labeled via GDR[3H]Man in
aninvitro reaction was purifiedandadded back tomembranes
in the presence of different detergent concentrations . When
the reactions were analyzed by SDS-PAGE and fluorography,
radiolabeled bands chromatographing with authenticmfVSG
species were observed only in a narrow range of detergent
concentrations (0.01 and 0.02% wt/vol, Triton X-100 ; Fig .
6) . No radioactivity was incorporated into protein if the re-
action contained<0.005% or >0.02% Triton X-100. As with
the GDR-[3H]Man-labeled VSG described above, these ra-
diolabeled proteins were PI-PLC sensitive, and could be im-
Figure 6. Transfer of purified [ 3H]Man-labeled P2 to endogenous
VSG acceptors. (A) P2, labeled via GDR[ 3H]Man in an in vitro
system was purified as described and 25,000 cpm of the purified
lipid ([3H]-P2) was dispersed in 25 A1 of0.02% (lanes 1 and 3) or
0.01% (lane 2) of Triton X-100 (wt/vol) in buffer 3 . Membranes
from tunicamycin-treated variant clone 117 (25 A1 ; 5 x 107 cell
equivalents) were preincubated at 0°C for 10 min without (lane 1
and 2) or with pCMPSA (GPI-PLC-inhibitor; lane 3) in buffer 3
without DTT, added to the above dispersion, and incubated for 90
min at 37°C . The reactions were solubilized and an aliquot (2 x
107 cell equivalents) analyzed bySDS-PAGE and fluorography . (B)
[3H]-P2 (20,000 cpm) was dispersed by sonication in 5 A1 buffer 3
containing 10 times the indicated detergent concentration (0-1.0%
w/v TritonX-100) and 45 Al ofbuffer 3 containing membranes from
tunicamycin-treated variant clone 117 (5 x 107 cell equivalents)
was added to each dispersion and processed as described above.
66Figure 7 . Protein synthesis is not required for GPI transfer. (A)
Membranes (50 Al ; 5 x 10' cell equivalents) from trypanosomes
(variant clone 117) were incubated in the absence or presence of
protein synthesis inhibitors (250 uM cycloheximide, 1 mM puro-
mycin, and 50 pM anisomycin ; final concentration) then added to
an equal volume of detergent solubilized [ 3H]P2 (25,000 cpm,
0.04% Triton X-100 in buffer 2 containing 2mM CoA, 400 ng/ml
tunicamycin, 0.4 mM GTP, 2 mM ATP, 16 U/nil creatine kingse,
20mM creatine phosphate) and processed for SDS-PAGE and fluo-
rography as described in Fig . 6 A . (B) Membranes from trypano-
somes (variant clone 118 ; 50 Al ; 2.5 x 10' cell equivalents) were
pre-incubated with protein synthesis inhibitors as above and 2 ACi
ofGDR[ 3H]Man was added to each tube. After incubation of the
reaction for 10 min at 37°C UDP-G1cNAc and GTP (1 mM each,
final concentration) were added . The reaction (100,ul in buffer 3)
was processed as described in Fig . 1 B.
munoprecipitated with antibodies to VSG 117 but not with
antisera to VSG 118 (data not shown) .
T . brucei membrane lysates contain a GPI-specific phos-
pholipaseC (GPI-PLC) that is capable of hydrolyzing P2 and
releasing GPI-anchored proteins (Bulow and Overath, 1986 ;
Fox et al ., 1986 ; Hereld et al ., 1986) . Thisenzyme has been
localized to the cytoplasmic surface of membrane-bound or-
ganelles but is absent from the plasma membrane, including
the region lining the flagellar pocket (Bulow et al ., 1989) .
Addition of detergent to solubilize the dried, labeled lipid
and deliver it to VSG may result in a hydrolytic destruction
of ['H]-P2 and prevent its utilization for the transfer reac-
tion . Todetermine the extent ofhydrolysis ofexogenous ['H]-
P2 by GPI-PLC during the transfer reaction, an aliquot of
the reaction mixture was analyzed for release of radioactivity
from the butanol-soluble ['H]-P2 into the aqueous phase as
described previously (Mayor et al ., 1990x) . Hydrolysis was
dependent on detergent concentration even though the lowest
detergent concentration adequately solubilized (verified by
determining radioactivity obtained in an aliquot of the reac-
tion buffer in the absence ofmembranes) the lipid in the reac-
tion buffer. Detergent concentrations of 0.1, 0.05, 0.02, 0.01,
and 0.005% wt/vol Triton X-100 resulted in 97, 92, 27, 27,
and 6%, respectively, of the PI-PLC destruction of ['H]-P2 .
In the absence of detergent, ['H]-P2 was not solubilized in
the reaction mixture and insignificant hydrolysis (<5% aque-
ous soluble radioactivity) was observed . Other detergents
(NP-40, n-octyl glucoside, or deoxycholate) at 0.02% (wt/
vol) were able to promote the hydrolytic destruction of ['H]-
P2, but failed to facilitate its delivery to VSG (data not
shown) . ['H]-P2 was efficiently solubilized in the reaction
buffer in the presence of ethanol (3% vol/vol), but neither
the transfer reaction norGPI-PLC hydrolysis were observed .
Efforts to inactivate the GPI-PLC by sodium p-chloromer-
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curiphenylsulphonate (pCMPSA) treatment (5 mM ; Hereld
et al ., 1986) or heat treatment (47°C, 10 min ; Bulow and
Overath, 1986) resulted in the inactivation of the transfer re-
action (Fig . 6 A, lane 3 and data not shown) . The low level
of radioactivity transferred to VSG was detected by fluorog-
raphy and the optical density ofthe labeled bands was taken
as an estimate of the transfer reaction . Quantitation of the
small amount of radioactivity transferred toVSG via exogen-
ously added lipid was not possible due to background scintil-
lation of the protosol-solubilized gel slices .
These data show that exogenously added ['H]-P2 can be
transferred to VSG in vitro and that the magnitude of the
transfer reaction is probably a compromise between "deliv-
ery" of the GPI, GPI-PLC-mediated hydrolysis, and disrup-
tion of membrane integrity.
Protein Synthesis IsNot RequiredforGPI Transfer
The incorporation of [35S]methionine into TCA-precipitable
material was very poor under conditions (0.02% Triton
X-100) that permitted the transfer ofexogenously added [ 3H]-
P2 to endogenous acceptors, and no radiolabeled proteins
were detected bySDS-PAGE and fluorographic analysis . Un-
derthese conditions, theadditionofcycloheximide (250 AM),
puromycin (1 mM) or anisomycin (50 /AM) had no effect on
the incorporation of ["S]methionine, nor was there any ef-
fect on the radiolabeling of the endogenous VSG acceptors
via exogenously added [ 3H]-P2 (Fig . 7 A) . These compounds
effectively inhibit protein synthesis in translationally active
trypanosome extracts (Moreno et al ., 1991) . Incubation of
the membrane preparation with protein synthesis inhibitors
had no effect on the transfer of GPIs, labeled via GDP-['H]-
Man, into endogenous acceptor VSGs from 118 (Fig . 7 B)
and 117 trypanosome membranes (data not shown) . These
data suggest that the transfer reaction does not require ongo-
ing protein synthesis and that GPIs are transferred to small
amounts of presynthesized acceptor VSG molecules trapped
in the membrane preparation .
EnergyRequirement ofthe Transfer of[3H]-P2
toEndogenous VSG Acceptors In Vitro
The presence ofATP in the lumen of the ER has yet to be
confirmed . A protein that is involved in "proofreading" newly
synthesized proteins in the secretory pathway (BiP or glucose
regulated protein 78) is an ATPase (Munro and Pelham,
1986), suggesting that ATP may cross the membrane of the
ER and participate in luminalreactions (Doureret al ., 1990) .
To determine whether the transfer of GPI molecules to en-
dogenous VSG acceptors requires an exogenous chemical
energy source, membranes were incubated along with deter-
gent solubilized [3H]-P2 in the absence or presence of an
ATP regeneratingsystem, ornonhydrolyzable ATP analogues.
No effect was observed on the transfer of ['H]-P2 to endog-
enous VSG under these conditions (Fig . 8) . The presence of
0.02% Triton X-100 was sufficient to abolish protease pro-
tection ofVSG labeled in vitro via GDP-['H]Man (data not
shown), indicating that the lumen of the ER is accessible to
the various additions . The effect ofATP and GTP hydrolysis
on ['H]-P2 addition to endogenous acceptors was also deter-
mined in the absence of added GTP by including ATP ana-
logues (1 mM ß-y-methyleneadenosine-5'-triphosphate and
1mM ß-y-imidoadenosine-5'-triphosphate), GTP analogues
67Figure 8 . ATP hydrolysis is not required for GPI transfer. Mem-
branes (50,1 ; 5 x 107cell equivalents) from trypanosomes (variant
clone 117) were added to an equal volume of detergent solubilized
[ 3H]-P2 (25,000 cpm, 0.04% Triton X-100 in buffer 2 containing
2mM CoA, 400 ng/ml tunicamycin, and 0.4mM GTP) inthe pres-
ence of various additions as indicated and incubated for 90 min at
37°C and processed for SDS-PAGE and fluorography as in Fig.
6 A . ATP/ CP/CK, 1mM ATP, 10mM creatine phosphate, and 8 U/
ml creatine kinase ; AMPPPCH Z P, 2 mM ß--y-methyleneadenosine-
5'-triphosphate ; AMPPNP, 2 mM 0--y-imidoadenosine-5'-triphos-
phate .
(1 mM ß-,y-immidoguanosine-5'-triphosphate, 1mM guano-
sine 5'-O-(3-thiotriphosphate)) or in the presence of anATP
depleting system (7.5 U/ml hexokinase and 2mM glucose) .
In the absence ofGTP, but in the presence of an ATP-regen-
erating system, nonhydrolyzableATP analogues, an ATP-de-
pleting system, or nonhydrolyzable analogues of GTP, simi-
lar amounts of radioactivity, as detected by fluorography,
were incorporatedintoendogenousVSGacceptors compared
to that observed in the presence ofGTP (data not shown) .
These observations suggestthat the transfer reaction does not
require an exogenous source of energy.
Tlransfer of OtherGPI Species
to EndogenousAcceptors
[3H]-P3, exogenously added to the membrane system, was
capable of being transferred to endogenous acceptors (Fig .
9 A) . Similar to the transfer of [3H]-P2, the transfer of [ 3H]-
P3 was dependent on the presence of a narrow range of de-
ergent concentrations (0.01 and 0.02% Triton X-100), in-
dependent ofATP orATP hydrolyses (data not shown), and
inhibited by pCMPSA . The VSG species labeled with ['H]-
P3 were PI-PLC resistant : PI-PLC treatment did not gener-
ate a gel mobility shift and the labeled VSG failed to become
aqueous solubleupon Triton X-114 detergent phase partition-
ing after PI-PLC treatment (data not shown) .
Other ethanolamine-containing GPI species that contain
the linear conserved sequence common to all of the GPI an-
chors but do not have sn-1,2-dimyristyl glycerol as the lipid
moiety (Table I) were also transferred to VSG in vitro . The
fatty acid remodeling intermediates P2' and P3, and an in-
sect stage-specific GPI molecule (PPI), similar to lyso-P3
(Field et al ., 1991), were purified and added to the mem-
brane preparation in the absence ofATP and CoA . Compara-
ble radioactivity (as detected by fluorography ; see above)
was incorporated into endogenous VSG species on addition
of6,500-20,000cpm ofthe differentGPI species, in the pres-
ence of0.02% Triton X-100 (Fig . 9 B) . No incorporation of
radioactivity into VSG was detected if <2,000 cpm . of the
Figure 9 . P3 and other GPI mole-
cules are substrates for the GPI
transfer reaction . (A) P3, labeled
via GDR[3H]Man in an in vitro
system was purified as described
and 25,000 cpm of the purified
lipid ([3H]P3) was dispersed in
25 Al of 0.02% (wt/vol) Triton
X-100 in buffer 3 . Membranes
were added to the above disper-
sion as described in Fig . 6A and
incubated for 90 min at 37°C.
The reactions were solubilized
and an aliquot (2 x 107 cell
equivalents) analyzed by SDS-
PAGE and fluorography . (B)
[3H]-labeled GPI-species were
dispersed by sonication in 5 A1
buffer 3 containing 10 times the
final detergent concentration
(0.01% wt/vol Triton X-100 in
buffer 2) and 45 Al of buffer 3
containing membranes from tuni-
camycin treated variant clone 117
(5 x 107 cell equivalents) was
added to each dispersion and pro-
cessed as described as above .
Lane 1, [3H]ethanolamine-labeled P2 (13,000 cpm) ; lane 2, [ 3H]Man-P2 (13,000 cpm) ; lane 3, [3H]Man-P2 (16,000 cpm) ; lane 4,
[3H]Man-P2' (16,000 cpm) ; lane 5, [ 3H]Man-P2" (6,500 cpm) ; lane 6, [ 3H]Man-P2" (19,600cpm) ; lane 7, [3H]Man-P3 (16,000cpm) ; lane
8, [ 3H]Man-P3 (16,000cpm) ; lane 9, [ 3H]ethanolamine-labeled P3 (16,000 cpm) ; lane 10, [ 3H]ethanolamine-labeled insect stage GPI (PPI ;
8,000 cpm) . GPIs in lanes 1, 2, 8, and 9 were TLC-purified from [ 3H]Man or [ 3H]ethanolamine-labeled bloodstream trypanosomes, GPIs
in lanes 3, 4, S, and 7 were TLC purified from lipids labeled in vitro via GDR[3H]Man, [ 3H]Man-P2" (lane 6) was purified by phase
separation of lipids labeled in vitro via GDR[3H]Man in the absence of ATP, and PPl in lane 10 was TLC-purified from insect stage trypano-
somes radiolabeled with [3H]ethanolamine (Field et al ., 1991) .
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68lipids, [3H]P2 or [3H]P3, were used in the reaction (data
not shown), ruling out the possibility that the labeling of
VSG observed in Fig. 9 B (lanes 4-10) was due to contami-
natingamounts ofotherGPIs. P3 and the PPl are intrinsically
resistant to GPI-PLC hydrolysis: 30-45% of the added P2,
P2; and P2" but <5% of P3 and PPl were hydrolyzed by
the endogenous GPI-PLC in the reactions described above.
TLC analyses of the intact lipids at the end of the reaction
showed that the lipid moiety of each of the GPI species was
unchanged (data not shown).
The data indicate that the transferase is capable of transfer-
ring P2, heterogeneously acylated forms of P2 (P2' and P2'ß,
PPl, and P3 to VSG in vitro, and suggest that the transferase
does not require a specific lipid moiety in the GPI molecule
to facilitate the transfer reaction. The transfer of [3H]-P2
and P3, labeled in the ethanolamine (Fig. 9 B; lanes 1 and
9), mannose (Fig. 9 B; lanes 2, 3, 7, and 8) and glucosamine
(data not shown) residues to endogenous VSG, provides evi-
dence that the GPI is added en bloc to VSG.
Discussion
In this paper we describe the transfer of free GPIs to endog-
enous VSG in a cell free system containing unfractionated
membranes prepared fromtunicamycin-treatedtrypanosomes.
The incorporation of radiolabel from GDR['H]Man into
GPI species and into VSG was totally dependent on the addi-
tionofexogenous UDP-G1cNAc; lackofsignificantglycolipid
and polypeptide labeling in the absence of added UDRGlc-
NAc indicated that VSG molecules were not labeled directly
via GDR['H]Man or via dol-P-['H]Man. The labeling of
two protein species was attributed to the presence of glyco-
sylated and unglycosylated forms of VSG acceptors in the
membrane due to the preparation of membranes from tuni-
camycin-treated trypanosomes. In vitro labeled VSGs were
protected fromproteolytic degradation to a significant extent
(20-25 %), consistent with a luminal location for the newly
translocated VSG acceptor polypeptides. However, the data
do not rule out the unlikely possibility that the reaction takes
place before the translocation of newly synthesized VSG.
Failure to observe a greater amount of proteolytic protection
ofthe labeled polypeptides may be due to themethod ofprepa-
rationofthemembranes,which involved hypotonic cell lysis.
Analyses ofthe ['H]Man-labeled moiety derived from gel-
purified in vitro-labeled mfVSG species showed that all the
radioactivity (>9S%) associated with VSG was present in a
glycan fragment that cochromatographed with the neutral
glycan species from a nongalactosylated VSG membrane an-
chor. The radioactivity incorporated into mfVSG 117 at the
end ofa 90-min incubation (-4,000 cpm/10' cell equivalents)
provided an estimate of the amount of VSG acceptor in this
system. Taking the specific activity of the GPI species as
three times that of GDR['H]Man (due to the presence of
three mannoses in the GPI anchor and assuming no dilution
of the specific radioactivity) there appear to be 3,600 mole-
cules/cell(-60 fmol/10' cells) ofacceptor VSG species pres-
ent in the membrane preparation. Surprisingly, the level of
acceptor VSG appears to be consistently -10-fold lower in
membranes made from adifferent variant clone (118 trypano-
somes, three separate observations ; Mayor, S., unpublished
observations). At the present time it is difficult to find a rea-
son for this quantitative difference in acceptor levels. No at-
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temptwasmade to enhance thelevelofacceptor polypeptides
(and possibly the efficiency of the labeling reaction) by cou-
pling either of the membrane preparations to an mRNA trans-
lation system, since, despite considerable effortinthis labora-
tory, it has been impossible to observe processing ofproteins
synthesized in the presence of trypanosome membranes (Ip,
H., unpublished observations), or processing of proteins
translated de novo from mRNA added to a trypanosome ly-
sate (Moreno et al., 1991).
Transfer ofpurified, exogenously added, labeled P2 (['H]-
P2) to endogenous VSG acceptors was also observed in this
cell free system. Thelabeledpolypeptides wereindistinguish-
able from the VSG species that were labeled by GPI species
synthesized in situ. These protein species were PI-PLC suscep-
tibleand could be immunoprecipitated by antibodies to VSG.
This observation directly demonstrates the precursor-prod-
uct relationship between P2 and the GPI anchor of mfVSG.
Pulse-chase experiments show that the reaction observed in
vitro is not a simple exchange reaction between newly syn-
thesized GPIs and preexisting GPI-anchored VSG, and trans-
fer of ['H]-P2 to endogenous VSG indicates that the GPI is
transferred en bloc to VSG. However, the data do not rule
out the unlikely possibility of more complex exchanges be-
tween GPI fragments (G1cN-PI or any fragment ofthe same).
In this context, the observation ofpartial anchors on a fusion
protein containing the carboxy terminus of Thy-1 may result
from anchor degradation or complex exchanges rather than
partial anchor component addition as suggested previously
(Kaetzel et al., 1990) .
The transfer ofexogenous GPI species to VSG was depen-
dent on the presence of detergent in a narrow concentration
range. The requirement for proper membrane integrity has
been observed as a prerequisite for a number of membrane-
associated enzymes (Fleischer and Fleischer, 1967) and is
likely to be the reason for the lack of transfer at the higher
detergent concentrations. Oligosaccharyl transferases from
a variety of sources are resident ER enzymes that also display
such arequirement (Kaplan et al., 1987; Chalifour and Spiro,
1988) .
The absence ofthe effect of protein synthesis inhibitors in-
dicates that the cell free transfer reaction takes place on poly-
peptide acceptors that have already been translated in vivo
and are present in the membrane preparation. The lack of an
energy requirement for the transfer reaction supports a trans-
peptidation reaction mechanism involving cleavage of the
carboxy-terminal extension of the protein and attachmentof
the free amine group of the GPI substrates to the carboxy-
terminal amino acid of the mature protein. However, at this
stage it is not clear whether the acceptor VSG molecules con-
tain the carboxy-terminal extension. Transpeptidases have
been described in the penicillin-sensitive peptidoglycan po-
lymerization reaction involved in cell wall formation of pro-
karyotes, mainlyGram-negativeEscherichiacoli (Izaki etal.,
1968)and gram positive Staphylococcus aureus (Tipper and
Strominger, 1968). Similar transpeptidation reactions are
carried out by a variety of peptidases (Lutek et al., 1988;
Berne et al ., 1990) and y-glutamyl transpeptidases (Walsh,
1979). Maturation of Concanavalin A into a carbohydrate
binding protein injackbean cotyledons (Bowles et al., 1986)
and the "splicing" of the 119-kD yeast TFP1 gene product to
a 69-kD subunit of the vacuolar proton-translocatiog adeno-
sine triphosphatase (Kane et al., 1990), are also possible ex-
69amples of such a reaction, but no definite mechanistic proof
for transpeptidation exists.
PI-PLC-sensitive and -resistant GPIs (P2 and P3) are
synthesized in vivo (Krakow et al., 1986; Menon et al .,
1988a) and in cell-free GDP-['H]Man-labeling experiments
(Masterson et al., 1989; Menon et al., 1990b) but only PI-
PLC-sensitive VSGs are detected in vivo and in vitro. VSG
is expressed only in the bloodstream stage of the parasite;
insect stage parasites express a major PI-PLC-resistant GPI-
anchored cell surface glycoprotein (Clayton and Mowatt,
1989) and recent analyses show that this stage ofthe parasite
synthesizes only PI-PLC-resistant free GPI species of which
the most prominent, PPl, is similar to lyso P3 (Field et al.,
1991). The results presented here show that, besides P2, PT,
and P2", the PI-PLC-resistant GPIs, P3, and PPl, were all
transferred to endogenous VSG acceptors in vitro. The P3-
labeled VSG was PI-PLC resistant. These data suggest that
the protein sequence does not determine the nature of the
GPI moiety transferred to the polypeptide. The low level of
incorporation of radioactivity into endogenous VSG prohib-
ited a kinetic analysis of the transfer of the different GPI
species.
Some possible models to account for these observations
are proposed. Firstly, the cell free system may not reflect the
true selectivity of the transfer process or the actual Kms of
the transferase for the different lipid substrates are vastly dif-
ferent in vivo. Alternatively, both PI-PLC-sensitive and re-
sistant GPIs are equally good substrates but an inositol de-
acylase, activeonly inthe VSG-expressing bloodstreamstage,
is inactivated in vitro, possibly due to the addition of deter-
gent. A third possibility is that PI-PLC sensitive and resis-
tant GPIs are synthesized via parallel pathways but in the
bloodstream stage only the PI-PLC-sensitive forms are de-
livered to the transferaseand in the insect stage PI-PLC-resis-
tant lipids become accessible to the transferase (either by the
removal of physical constraints or Km differences). The first
and third possibilities are not mutually exclusive. The trans-
fer of P3 and PPl to VSG in vitro supports the second possi-
bility and is consistentwith the proposal ofa developmentally
regulated deacylase, active in the bloodstream stage and in-
active in the insect stage. However, at this stage there is no
evidence for such an enzyme, nor has the PI-PLC suscepti-
bility of the PPl-labeled VSG been determined.
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